Ossur applies for listing on NASDAQ OMX Copenhagen
The Board of Directors of Ossur hf. has today decided to apply for
listing of the Company's shares on NASDAQ OMX Copenhagen. Ossur's
shares will continue to be listed on NASDAQ OMX Iceland as they have
been since 1999.
An additional listing on NASDAQ OMX Copenhagen is believed to make
strong strategic sense for the Company. Copenhagen offers access to
the international investor community and is a recognized market for
healthcare companies. Listing and compliance requirements are similar
in Denmark and Iceland and both exchanges are part of the NASDAQ OMX
Nordic group.
Jon Sigurdsson, President & CEO: "The listing of our shares in
Iceland has served us well and we remain committed to all current and
future shareholders. Since our initial listing, our sales have grown
more than twenty times and we have transformed into a global company.
The additional listing in Copenhagen is a logical next step for us.
It is aimed at facilitating trade and fair pricing of our shares and
strengthening the Company's foundation for future growth."
The new listing is expected to be approved next week. Nordea Bank
will be the issuing agent in Denmark. Further information will be
disclosed when the application for listing has been approved.
Following the listing the Board of Directors will, in order to
facilitate liquidity, consider a modest issue of new shares
corresponding to 5-7% of the Company's share capital. Such an issue
would be directed towards institutional investors and in this
connection Ossur has engaged Nordea Markets as financial advisor.
Trading with Icelandic financial instruments is currently subject to
Icelandic Foreign Exchange Rules. Investors domiciled outside Iceland
will, in general, be able to trade Ossur shares freely on the Danish
market. Investors domiciled in Iceland can trade Ossur shares freely
on the Icelandic market.
Further information on Ossur, including an introduction brochure and
additional information on the trading of Ossur shares and transfer
between Iceland and Denmark can be found on Ossur's website:
www.ossur.com/investors
Ossur contacts:
Jon Sigurdsson, President & CEO, tel. +354 515 1300
Hjorleifur Palsson, CFO, tel. +354 515 1300
Sigurborg Arnarsdottir, IR Manager, tel. +354 664-1044
About Ossur
Ossur (OMX: OSSR) is a global leader in non-invasive orthopaedics
that help people live a life without limitations. Its business is
focused on improving people's mobility through the delivery of
innovative technologies within the fields of bracing and supports,
prosthetic limbs and compression therapies. A recognized "Technology
Pioneer", Ossur invests significantly in research and product
development; its award-winning designs ensuring a consistently strong
position in the market. Successful patient and clinical outcomes are
further empowered via Ossur's educational programs and business
solutions. Headquartered in Iceland, Ossur has major operations in
North America and Europe, with additional distributors worldwide.